These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22588878)

  • 1. Emerging epigenetic targets and therapies in cancer medicine.
    Popovic R; Licht JD
    Cancer Discov; 2012 May; 2(5):405-13. PubMed ID: 22588878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
    Simó-Riudalbas L; Esteller M
    Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
    Mohammad HP; Barbash O; Creasy CL
    Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting epigenetic enzymes for autism treatment.
    Yan Z
    Trends Pharmacol Sci; 2024 Sep; 45(9):764-767. PubMed ID: 39034229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are epigenetic drugs for diabetes and obesity at our door step?
    Arguelles AO; Meruvu S; Bowman JD; Choudhury M
    Drug Discov Today; 2016 Mar; 21(3):499-509. PubMed ID: 26697737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
    Wang Z; Patel DJ
    Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and potential epigenetic targets in multiple myeloma.
    Pawlyn C; Kaiser MF; Davies FE; Morgan GJ
    Epigenomics; 2014 Apr; 6(2):215-28. PubMed ID: 24811790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin proteins and modifications as drug targets.
    Helin K; Dhanak D
    Nature; 2013 Oct; 502(7472):480-8. PubMed ID: 24153301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic agents in combined anticancer therapy.
    Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
    Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
    Liu K; Liu Y; Lau JL; Min J
    Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors.
    Kumar A; Emdad L; Fisher PB; Das SK
    Adv Cancer Res; 2023; 158():73-161. PubMed ID: 36990539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Tsai CT; So CW
    Oncogene; 2017 Mar; 36(13):1753-1759. PubMed ID: 27593928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic-based therapies in cancer: progress to date.
    Song SH; Han SW; Bang YJ
    Drugs; 2011 Dec; 71(18):2391-403. PubMed ID: 22141383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.
    Gelato KA; Adler D; Ocker M; Haendler B
    Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.